It was reported that a (b)(6) female patient with history of breast prosthesis implantations was diagnosed with left breast cancer.The patient was implanted with mentor smooth round gel mammary prostheses on (b)(6) 2005.(catalog # 350-7300bc, serial number left side (b)(4) and serial number right side (b)(4)).The patient had a mammogram done on 10/20/2015 that showed ¿some micro calcifications in the left superior breast¿ and recommended patient attempt to obtain prior mammogram images for comparison and for additional imaging (spot magnification views) to evaluate the micro calcifications.They also recommended ultrasound at the discretion of the radiologist.Conclusion on calcifications was bi-rads category: 0- incomplete: needs additional imaging evaluation.Additional mammograms were done on (b)(6) 2016 and (b)(6) 2017.A bilateral breast mri was done on (b)(6) 2017 due to recent diagnosis of left breast cancer (exact date of diagnosis is unknown) the mri was done to assess extent of disease and for possible contralateral disease.Mri confirmed that bilateral implants were ruptured.Mri report ((b)(6) 2017) cites patient had augmentation revision procedure in 2008 (no further information stated; no information on types or brand of implants used).The patient has no family or personal history of breast cancer before this diagnosis.Patient advised that she had not selected an explant surgeon or explant surgery date as of yet.Mentor made a decision to file a fda medwatch report based on the above information; however, currently, there is no solid evidence in the literature to suggest that breast implant rupture alter the risk of breast malignancies.
|